March 26, 2024

FDA Clearance for Neuronetics’ Adjunct Treatment for Depression in Adolescents

 Medical technology company, Neuronetics, Inc. (Nasdaq: STIM), has received clearance from the FDA for its NeuroStar Advanced Therapy for use as an adjunct for the treatment of major depressive disorder (MDD) in adolescent patients. This is the fourth FDA-cleared indication for NeuroStar. “The current treatment options available for adolescents are extremely limited, compared to those… [Read More]
March 26, 2024

AIM ImmunoTech Publishes Early Access Data in Prestigious Oncology Journal

Immuno-pharma company, AIM ImmunoTech (NYSE American: AIM) has published a new data analysis from a long-term Early Access Program studying the company’s drug Ampligen® (rintatolimod) for the treatment of advanced pancreatic ductal adenocarcinoma (PDAC). The company’s research, titled, “Rintatolimod in Advanced Pancreatic Cancer enhances Anti-Tumor Immunity through Dendritic Cell-Mediated T Cell Responses,” appears in the… [Read More]
March 26, 2024

Stocks making the biggest moves premarket: Krispy Kreme, UPS, Micron Technology and more

Don’t miss the companies making waves in early-market trading. Krispy Kreme — The company’s stock skyrocketed almost 14% in premarket following the announcement of their donuts being available in McDonald’s outlets across the nation by end-2026, launching later this year. Testing began in selected McDonald’s in 2022, and this expanded collaboration can potentially double Krispy… [Read More]
March 25, 2024

Seelos Misses Endpoints in Blow to ALS Community

Biopharmaceutical company, Seelos Therapeutics (Nasdaq: SEEL) has missed primary and secondary endpoints in its Phase 2/3 HEALEY ALS Platform trial of SLS-005 in a blow to the ALS community. The company’s shares dropped by more than 50% to reach a record low in trading last week. SLS-005 previously received Orphan Drug Designation for the treatment… [Read More]
March 25, 2024

Stocks Retreat as Investors Look for New Drivers: Market Overview

Following the S&P 500’s strongest week of the year, US equity futures edged lower as investors awaited further developments that might influence the Federal Reserve’s decision-making. The S&P 500 futures dropped by 0.3%, while Nasdaq 100 futures decreased by approximately 0.5%. In Europe, the Stoxx Europe 600 index saw a decline after a nine-week winning… [Read More]
March 25, 2024

BrainsWay Receives Significant New Order for Deep TMS™ Systems

Mental health company, BrainsWay Ltd. (Nasdaq: BWAY) has received an order for 18 of its Deep Transcranial Magnetic Stimulation (Deep TMS™) systems from Katie’s Way Plus. BrainsWay’s patented, clinically validated, Deep TMS system offers an in-office breakthrough treatment using flexible H-Coils embedded in a comfortable helmet to noninvasively activate targeted brain structures. Katie’s Way Plus… [Read More]